Comparison

Carperitide European Partner

Item no. HY-P1235-1ea
Manufacturer MedChem Express
CASRN 89213-87-6
Amount 1 ea
Quantity options 100 mg 1 ea 1 mg 500 ug 5 mg
Category
Type Peptides
Specific against other
Formula C127H203N45O39S3
Citations Biofabrication. 2023 Mar 10.
J Cell Mol Med. 2021 Oct;25(20):9660-9673.
Mol Biol Rep. 2024 Apr 15;51(1):506.
[1]Kohno M, et al. Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin II in porcine aorta. Circ Res. 1992 Feb;70(2):241-7.
[2]Kohno M, et al. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J Clin Invest. 1991 Jun;87(6):1999-2004.
[3]Ballermann BJ, et al. Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli. J Clin Invest. 1985 Dec;76(6):2049-56.
Smiles OC(C=C1)=CC=C1C[C@@H](C(O)=O)NC([C@H](CCCNC(N)=N)NC([C@@H](NC([C@H](CO)NC([C@H](CC(N)=O)NC([C@@H]2CSSC[C@@H](C(N[C@H](C(NCC(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(NCC(N2)=O)=O)CC(C)C)=O)=O)CO)=O)CCC(N)=O)=O)C)=O)=O)([H])[C@@H](C)CC)=O)CCCNC(N)=N)=O)CC(O)=O)=O)CCSC)=O)CCCNC(N)=N)=O)=O)=O)CC3=CC=CC=C3)=O)NC([C@H](CO)NC([C@H](CO)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@@H](N)CO)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC4=CC=CC=C4)=O)=O
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Atrial Natriuretic Peptide (ANP) (1-28), human, porcine
Shipping condition Room temperature
Available
Manufacturer - Type
Peptides
Manufacturer - Applications
Metabolism-protein/nucleotide metabolism
Manufacturer - Targets
Endothelin Receptor
Shipping Temperature
Room Temperature
Molecular Weight
3080.44
Product Description
Carperitide (Atrial Natriuretic Peptide (ANP) (1-28), human, porcine) is a 28-amino acid hormone, that is normally produced and secreted by the human heart in response to cardiac injury and mechanical stretch. Carperitide (Atrial Natriuretic Peptide (ANP) (1-28), human, porcine) inhibits endothelin-1 secretion in a dose-dependent way.
Manufacturer - Research Area
Cardiovascular Disease; Endocrinology
Solubility
10 mM in H2O
Manufacturer - Pathway
GPCR/G Protein
Clinical information
Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close